Common rheumatoid arthritis treatment may be effective in treating immunoglobulin G4-related disease
Sunday, October 27, 2013 - 12:30
in Health & Medicine
Rituximab (Rituxan®) — a drug commonly used rheumatoid arthritis, granulomatosis with polyangiitis (formerly Wegener’s), and certain types of cancers — may be a safe and effective treatment for immunoglobulin G4-related disease (commonly called IgG4-RD), according to new research.